US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
U.S. drug company Merck to share license for experimental covid-19 treatment with non-profit
US BioPharmaceutical company, Merck, to make the treatment available to millions of people in mostly low- and middle-income nations.
World
More Stories
Biden Accelerates Semi Conductor Chip Manufacturing Funding Initiatives Before End of Term
Biden Seeks $100 Billion Emergency Disaster Relief from Congress
Nvdia and Meta Request Supreme Court Exemptions From Lawsuits